I am an attending physicist and Chief of the Imaging and Spectroscopic Physics Service in the Department of Medical Physics. I joined Memorial Sloan Kettering in 1985 to develop a program in biological magnetic resonance.
Previously, I trained in Boston at City Hospital, Dana Farber Cancer Institute, and Massachusetts General Hospital after receiving medical and doctorate degrees from the State University of New York, where I participated in one of the original groups that developed MRI in the 1970s.
My research focuses on studying tumor metabolism and microenvironments, with the goals of developing new therapeutic targets and enhancing the interaction of radiation and chemotherapy to improve treatment outcomes. Currently, I am conducting preclinical studies to block breast and prostate tumor growth by inhibiting several key steps required to generate energy and important biomolecules. I have published research focusing on clinical and preclinical studies in both MRI and cancer journals.
I am also a board-certified oncologist specializing in the care of patients with prostate cancer, but I also see some patients with bladder and kidney cancer. I am member of the International Society of Magnetic Resonance in Medicine.
- Clinical Expertise: Prostate Cancer; Genitourinary Malignancies
- Languages Spoken: English
- Education: MD, PhD, State University of New York Downstate College of Medicine
- Residencies: Boston City Hospital
- Fellowships: Boston City Hospital; Dana-Farber Cancer Institute; Massachusetts General Hospital
- Board Certifications: Internal Medicine; Medical Oncology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more